United Kingdom · Funded startup

Who invested in Antidote

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$11Mraised across 1 round since 2017, from 1 source

Latest round
Round, $11MSept 2017
Investors
2
See who backed them

The rounds

  1. Sept 2017
    Round$11M
    • Octopus
    • Merck Global Health Innovation Fund/ Smedvig

    Reported by FinSMEs

Everyone who backed them

OctopusHedge fund1round
Merck Global Health Innovation Fund/ Smedvigno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Antidote as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Initial CapitalVC firmPer its own site

Quick answers about Antidote

Who invested in Antidote?

Antidote's investors include Octopus and Merck Global Health Innovation Fund/ Smedvig.

How much has Antidote raised?

Antidote has raised $11M across 1 round since 2017.

When did Antidote last raise?

Antidote's most recent round was an Undisclosed round of $11M in Sept 2017.

What was Antidote's biggest round?

Its most recent round, $11M in Sept 2017, is also its largest on record.

Who backed Antidote first?

Antidote's first round on record, in Sept 2017, was backed by Octopus and Merck Global Health Innovation Fund/ Smedvig.

What stage is Antidote at?

Antidote's latest named round is an Undisclosed round, in Sept 2017.

Where is Antidote based?

Antidote is based in the United Kingdom.

Companies like Antidote

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.